Author Archive: AZBio
Critical Path Institute Launches New Neonatal Consortium
The International Neonatal Consortium (INC) aims to accelerate the development of safe, effective therapies for newborns.Continue reading
Connecting to Research Funding: A look at Benefunder
Benefunder Launches Charitable Innovation Fund to Connect Donors With Top Researchers New High-Impact Philanthropic Product Gives Savvy Advisors an ‘Edge’Continue reading
AZBio Members VisionGate and NextPotential in Innovation Challenge Top 25
The Arizona Commerce Authority (ACA) has announced 25 semifinalists in its Spring 2015 Arizona Innovation Challenge (AIC), a bi-annual business plan competition awarding $3 million annually to talented entrepreneurs.Continue reading
AZBio Submits Comments On How SB1475 Will Increase Healthcare Costs
While AZBio and its members recognize that the State of Arizona and the legislature must work diligently to balance the State Budget – which includes implementation of SB1475 and a 5% rate cut to providers of healthcare services – the end result may ultimately increase the state’s healthcare spend rather than reduce it.Continue reading
Study of triple-negative breast cancer is most cited in AACR journal
TGen, Baylor, US Oncology study revealed therapeutic drug targets for aggressive form of breast cancerContinue reading
Success Stories: Pinnacle Transplant Honored in Phoenix
Pinnacle Transplant Technologies takes home Phoenix Chamber Impact Award for business of the yearContinue reading
How Research and Technology at Phoenix Children’s are leading to better patient outcomes.
Hospital Week 2015: A look at the work being done at Phoenix Children’s Hospital Continue reading
ASU professor Charles Arntzen named Fast Company’s Most Creative Person in Business
Arizona State University Biodesign Institute researcher Charles Arntzen has been chosen as the No. 1 honoree among Fast Company’s annual “100 Most Creative People in Business” for his leadership role in developing ZMapp, a therapeutic produced in tobacco to fight Ebola.Continue reading
Arizona Poison Centers Welcome Approval of New Snake Antivenom, Plan Research
Tucson, Phoenix Toxicologists To Assess DrugsContinue reading